Login
$BIIB
$251.65 -$1.75 (0.69%) Live

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Joined 2025 pay Source
Christopher A. Viehbacher Also a director
President, Chief Executive Officer
65 Since 2022
4 years
2022 $23,646,004
Robin C. Kramer
Executive Vice President and Chief Financial Officer
60 Not stated Not stated $5,806,584
Susan H. Alexander
Executive Vice President, Chief Legal Officer
69 Since 2018
8 years
Not stated $8,132,517
Ginger Gregory
Executive Vice President and Chief Human Resources Officer
58 Since 2017
9 years
Not stated Not reported
Sean Godbout
Vice President, Chief Accounting Officer and Global Corporate Controller
52 Since 2025
1 year
Not stated Not reported
Michael Parini
Chief Legal Officer
Title from the Form 4 dated Sep 1, 2026
Not stated Not stated Not stated Not reported
Nicole Murphy
Executive Vice President, Pharmaceutical Operations and Technology
53 Since 2022
4 years
Not stated $7,575,505
Rachid Izzar
Executive Vice President, Global Product Strategy and Commercialization
51 Since 2021
5 years
Not stated Not reported
Priya Singhal
Executive Vice President, Head of Development
58 Since 2023
3 years
Not stated $7,571,387
Jane Grogan
Executive Vice President, Head of Research
59 Not stated Not stated Not reported
Adam Keeney
Executive Vice President, Head of Corporate Development
49 Since 2023
3 years
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
11
serving now
Independent
9 of 10
stated in the proxy; 1 not stated
Average tenure
6.3 years
from year joined
CEO also chairs the board
No
Maria C. Freire
Director Age On board Independent Committees Other public boards 2025 pay Source
Maria C. Freire
71 2021
5 years
Independent
Corporate Governance Committee Compensation and Management Development Committee
Alexandria Real Estate Equities, Inc. $457,447
Christopher A. Viehbacher
66 2022
4 years
Not independent None stated None stated Paid as CEO
Lloyd Minor
68 2024
2 years
Independent
Audit Committee
Caris Life Sciences, Inc. $439,947
Eric K. Rowinsky
69 2010
16 years
Independent
Corporate Governance Committee Compensation and Management Development Committee
Purple Biotech Ltd. $454,947
William A. Hawkins
72 2019
7 years
Independent
Audit Committee Corporate Governance Committee
Bioventus, Inc. $462,447
Menelas Pangalos
59 2025
1 year
Independent
Compensation and Management Development Committee
Absci Corporation $439,947
Stephen A. Sherwin
77 2010
16 years
Independent
Audit Committee
Neurocrine Biosciences Inc. $439,947
Susan K. Langer
35 2023
3 years
Independent
Compensation and Management Development Committee
None stated $439,947
Monish Patolawala
56 2024
2 years
Independent
Audit Committee · Chair
None stated $447,447
Jesus B. Mantas
57 2019
7 years
Independent
Compensation and Management Development Committee · Chair
International Flavors and Fragrances Inc. $459,947
Caroline D. Dorsa Leaving at the meeting
Not stated Not stated Not stated
Corporate Governance
None stated $629,930

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support